Vicki Osborne

Summary

Affiliation: Drug Safety Research Unit
Country: UK

Publications

  1. doi request reprint Utilisation of extended release quetiapine (Seroquel XL™): Results from an observational cohort study in England
    V Osborne
    Drug Safety Research Unit, Bursledon Hall, Blundell Lane, Southampton SO31 1AA, UK Electronic address
    Eur Psychiatry 33:61-7. 2016
  2. doi request reprint Incidence of venous thromboembolism in users of strontium ranelate: an analysis of data from a prescription-event monitoring study in England
    Vicki Osborne
    Drug Safety Research Unit, Bursledon Hall, Southampton, UK
    Drug Saf 33:579-91. 2010
  3. doi request reprint Examining the utilization and tolerability of the non-sedating antihistamine levocetirizine in England using prescription-event monitoring data
    Deborah Layton
    Drug Safety Research Unit, Southampton, UK
    Drug Saf 34:1177-89. 2011
  4. doi request reprint Drug utilization of Intrinsa (testosterone patch) in England: interim analysis of a prescription-event monitoring study to support risk management
    Vicki Osborne
    Drug Safety Research Unit, Bursledon Hall, Southampton, UK
    Drug Saf 33:213-21. 2010
  5. pmc Indicators of drug-seeking aberrant behaviours: the feasibility of use in observational post-marketing cohort studies for risk management
    Deborah Layton
    Drug Safety Research Unit, Bursledon Hall, Blundell Lane, Southampton, SO31 1AA, UK
    Drug Saf 37:639-50. 2014

Detail Information

Publications5

  1. doi request reprint Utilisation of extended release quetiapine (Seroquel XL™): Results from an observational cohort study in England
    V Osborne
    Drug Safety Research Unit, Bursledon Hall, Blundell Lane, Southampton SO31 1AA, UK Electronic address
    Eur Psychiatry 33:61-7. 2016
    ..A post-authorisation safety study was carried out as part of the EU Risk Management Plan to examine the long-term (up to 12 months) use of quetiapine XL as prescribed in general practice in England...
  2. doi request reprint Incidence of venous thromboembolism in users of strontium ranelate: an analysis of data from a prescription-event monitoring study in England
    Vicki Osborne
    Drug Safety Research Unit, Bursledon Hall, Southampton, UK
    Drug Saf 33:579-91. 2010
    ..Strontium ranelate is indicated for the treatment of postmenopausal osteoporosis. An association between strontium ranelate and venous thromboembolism (VTE) was identified in an analysis of phase III clinical trials...
  3. doi request reprint Examining the utilization and tolerability of the non-sedating antihistamine levocetirizine in England using prescription-event monitoring data
    Deborah Layton
    Drug Safety Research Unit, Southampton, UK
    Drug Saf 34:1177-89. 2011
    ..Levocetirizine was launched onto the UK market in September 2001. It is indicated for symptomatic treatment of allergic rhinitis (AR), including persistent AR and chronic idiopathic urticaria...
  4. doi request reprint Drug utilization of Intrinsa (testosterone patch) in England: interim analysis of a prescription-event monitoring study to support risk management
    Vicki Osborne
    Drug Safety Research Unit, Bursledon Hall, Southampton, UK
    Drug Saf 33:213-21. 2010
    ....
  5. pmc Indicators of drug-seeking aberrant behaviours: the feasibility of use in observational post-marketing cohort studies for risk management
    Deborah Layton
    Drug Safety Research Unit, Bursledon Hall, Blundell Lane, Southampton, SO31 1AA, UK
    Drug Saf 37:639-50. 2014
    ..One of the exploratory objectives included estimating the prevalence of aberrant behaviours during FEBT treatment...